您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2017, Vol. 55 ›› Issue (6): 87-92.doi: 10.6040/j.issn.1671-7554.0.2017.350

• • 上一篇    下一篇

健康管理人群代谢综合征发病风险预测模型

孙苑潆1,2,杨亚超3,曲明苓3,陈雁敏3,李敏1,2,王淑康1,2,薛付忠1,2,刘云霞1,2   

  1. 1.山东大学公共卫生学院生物统计学系, 山东 济南 250012;2.山东大学齐鲁生物医学大数据研究中心, 山东 济南 250012;3.威海市立医院健康体检科, 山东 威海 264200
  • 收稿日期:2017-04-24 出版日期:2017-06-10 发布日期:2017-06-10
  • 通讯作者: 杨亚超. E-mail:790587538@qq.com E-mail:790587538@qq.com
  • 基金资助:
    国家自然科学基金(81273177)

A prediction model for metabolic syndrome risk: a study based on the health management cohort

SUN Yuanying1,2, YANG Yachao3, QU Mingling3, CHEN Yanmin3, LI Min1,2, WANG Shukang1,2, XUE Fuzhong1,2, LIU Yunxia1,2   

  1. 1. Department of Biostatistics, School of Public Health, Shandong University, Jinan 250012, Shandong, China;
    2. Cheeloo Research Center for Biomedical Big Data, Shandong University, Jinan 250012, Shandong, China;
    3. Physical Examination Department, Weihai Municipal Hospital, Weihai 264200, Shandong, China
  • Received:2017-04-24 Online:2017-06-10 Published:2017-06-10

摘要: 目的 基于健康管理人群队列,构建代谢综合征的5年发病风险预测模型。 方法 依托山东多中心健康管理纵向观察队列,选取20~80岁且基线未患代谢综合征者构建队列,采用Cox比例风险回归构建预测模型,并利用十折交叉验证法检验模型的稳定性,通过受试者工作特征曲线(ROC)下面积(AUC)和观测/期望(OE比)评价模型的预测效果。 结果 随访期间共发生代谢综合征1 591例(男1 273例,女318例),发病密度为38.57/1 000人年。男性代谢综合征预测模型纳入的变量包括年龄、BMI、空腹血糖、甘油三酯、高密度脂蛋白、血尿酸、总胆固醇和是否高血压,女性模型纳入变量包括年龄、BMI、空腹血糖、甘油三酯、血尿酸和是否高血压;模型ROC曲线下面积分别为0.751(95%CI:0.742~0.759)和0.745(95%CI:0.734~0.756);OE比分别为1.03和1.00;十折交叉验证ROC曲线下面积平均值分别为0.749和0.746。 结论 本研究利用健康管理纵向队列数据,建立了代谢综合征5年发病风险预测模型,经十折交叉验证结果表明,其在健康管理人群中有较好的预测效果,有助于识别高发病风险人群,进而减少和预防代谢综合征的发生。

关键词: 代谢综合征, 健康管理人群, Cox比例风险回归, 纵向队列, 风险预测模型

Abstract: Objective To construct a model to evaluate the risk of developing metabolic syndrome(MetS)within 5 years in Chinese mainland Han population based on a health management population. Methods A total of 15 872 people without MetS at baseline were included based on the Shandong Multi-center Longitudinal Cohort for Health Management. Cox proportional hazards regression model was used to build the prediction model and the discriminatory ability was evaluated with area under the receiver operating characteristic(ROC)curve(AUC)and observed/expected counts(OE ratio). Results A total of 1 591 new MetS cases(1 273 males and 318 females)were observed during the follow-up of 5 years, accounting for an incidence density of 38.57/1000 person-year. In the male model, the risk factors included age, body mass index(BMI), fasting blood-glucose(FBG), triglyceride(TG), high density lipoprotein cholesterol(HDL-C), uric acid(UA), total cholesterol and hypertension. In the female model, the risk factors included age, BMI, FBG, TC, UA and hypertension. The AUC was 0.751(95%CI: 0.742-0.759)and 0.745(95%CI: 山 东 大 学 学 报 (医 学 版)55卷6期 -孙苑潆,等.健康管理人群代谢综合征发病风险预测模型 \=- 0.734-0.756)in the male and female model, respectively. The OE ratio was 1.03 and 1.00 in the male and female model, respectively. Conclusion This study has constructed a 5-year risk model that could be informative for identifying individuals at a high risk of developing MetS in a health management population.

Key words: Health management population, Metabolic syndrome, Longitudinal cohort, Prediction model, Coxs proportional hazards regression

中图分类号: 

  • R589
[1] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华内分泌代谢杂志, 2014, 30(10): 26-89. Chinese Diabetes Society. China guideline for type 2 diabetes[J]. Chin J Endocrinol Metab, 2014, 30(10): 26-89.
[2] Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey[J]. JAMA, 2002, 287(3): 356-359.
[3] Beltrán-Sánchez H, Harhay MO, Harhay MM, et al. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010[J]. J Am Coll Cardiol, 2013, 62(8): 697-703.
[4] Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syndrome and overweight among adults in China[J]. Lancet, 2005, 365(9468): 1398-1405.
[5] Villegas R, Xiang YB, Yang G, et al. Prevalence and determinants of metabolic syndrome according to three definitions in middle-aged Chinese men[J]. Metab Syndr Relat Disord, 2009, 7(1): 37-45.
[6] Li G, de Courten M, Jiao S, et al. Prevalence and characteristics of the metabolic syndrome among adults in Beijing, China[J]. Asia Pac J Clin Nutr, 2010, 19(1): 98-102.
[7] Xiao J, Wu CL, Gao YX, et al. Prevalence of metabolic syndrome and its risk factors among rural adults in Nantong, China[J]. Sci Rep, 2016, 6: 38089. doi: 10.1038/srep38089.
[8] Kassi E, Pervanidou P, Kaltsas G, et al. Metabolic syndrome: definitions and controversies[J]. BMC Med, 2011, 9: 48. doi: 10.1186/1741-7015-9-48.
[9] Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study[J]. Atherosclerosis, 2004, 173(2): 309-314.
[10] Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement[J]. Circulation, 2005, 112(17): 2735-2752.
[11] Wilson PW, D'Agostino RB, Parise H, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus[J]. Circulation, 2005, 112(20): 3066-3072.
[12] Yang XH, Tao QS, Sun F, et al. Setting up a risk prediction model on metabolic syndrome among 35-74 year-olds based on the Taiwan MJ Health-checkup Database[J]. Chin J Epidemiol, 2013, 34(9): 874-878.
[13] Hsiao FC, Wu CZ, Hsieh CH, et al. Chinese metabolic syndrome risk score[J]. South Med J, 2009, 102(2): 159-164.
[14] 中华医学会糖尿病学分会代谢综合征研究协作组. 中华医学会糖尿病学分会关于代谢综合征的建议[J]. 中华糖尿病杂志, 2004, 12(3): 156-161. Metabolic syndrome research collaboration group from Chinese Diabetes Society. Suggestions on metabolic syndrome from Chinese Diabetes Society[J]. Chin J Diabetes, 2004, 12(3): 156-161.
[15] Kaur J. A comprehensive review on metabolic syndrome[J]. Cardiol Res Pract, 2014, 2014:943162. doi:10.1155/2014/943162.
[16] Jiang B, Li B, Wang Y, et al. The nine-year changes of the incidence and characteristics of metabolic syndrome in China: longitudinal comparisons of the two cross-sectional surveys in a newly formed urban community[J]. Cardiovasc Diabetol, 2016, 15:84. doi: 10.1186/s12933-016-0402-9.
[17] Lu J, Wang L, Li M, et al. Metabolic syndrome among adults in China - the 2010 China noncommunicable disease surveillance[J]. J Clin Endocrinol Metab, 2017, 102(2): 507-515.
[18] Sheu WH, Chuang SY, Lee WJ, et al. Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan[J]. Diabetes Res Clin Pract, 2006, 74(2): 162-168.
[19] Yu S, Guo X, Yang H, et al. An update on the prevalence of metabolic syndrome and its associated factors in rural northeast China[J]. BMC Public Health, 2014, 14: 877. doi: 10.1186/1471-2458-14-877.
[20] Tao LX, Li X, Zhu HP, et al. Association of hematological parameters with metabolic syndrome in Beijing adult population: a longitudinal study[J]. Endocrine, 2014, 46(3): 485-495.
[21] Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease[J]. Clin Res Cardiol, 2006, 95(3): 136-147.
[22] Zhou P, Meng Z, Liu M, et al. The associations between leukocyte, erythrocyte or platelet, and metabolic syndrome in different genders of Chinese[J]. Medicine, 2016, 95(44): e5189. doi: 10.1097/MD.0000000000005189
[23] Hwang LC, Bai CH, Chen CJ, et al. Gender difference on the development of metabolic syndrome: a population-based study in Taiwan[J]. Eur J Epidemiol, 2007, 22(12): 899-906.
[24] Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994[J]. Arch Intern Med, 2003, 163(4): 427-436.
[25] Li JB, Wang X, Zhang JX, et al. Metabolic Syndrome: prevalence and risk factors in southern China[J]. J Int Med Res, 2010, 38(3): 1142-1148.
[26] Wang F, Wu S, Song Y, et al. Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese[J]. Nutr Metab Cardiovasc Dis, 2009, 19(8): 542-547.
[27] Zhou XH, Song XX, Ji LN. The components of metabolic syndrome analyzed by factor analysis[J]. J Diabetes, 2005, 13(6): 434-436.
[28] Dai X, Yuan J, Yao P, et al. Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population[J]. Eur J Epidemiol, 2013, 28(8): 669-676.
[1] 周苗,卞伟玮,柳晓涓,康凤玲,薛付忠,刘静. 嗜碱性粒细胞百分比与慢性肾脏病关系的回顾性队列研究[J]. 山东大学学报(医学版), 2018, 56(3): 85-90.
[2] 周苗,夏同耀,孙爱玲,李明,申振伟,卞伟玮,蒋正,康凤玲,柳晓涓,薛付忠,刘静. 健康管理人群慢性肾脏病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 98-103.
[3] 苏萍,杨亚超,杨洋,季加东,阿力木·达依木,李敏,薛付忠,刘言训. 健康管理人群2型糖尿病发病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 82-86.
[4] 李江冰,宋心红,林海燕,张冬芝,李向一,许艺博,王丽,薛付忠. 健康管理人群缺血性异常心电图的影响因素[J]. 山东大学学报(医学版), 2017, 55(6): 77-81.
[5] 张光,王广银,吴红彦, 张红玉,王停停,李吉庆,李敏,康凤玲,刘言训,薛付忠. 健康管理人群高脂血症风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 72-76.
[6] 王春霞,许艺博,杨宁,夏冰,王萍,薛付忠. 基于健康管理队列的冠心病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 66-71.
[7] 李吉庆,赵焕宗,宋炳红,张理纯,李向一,陈亚飞,王萍,薛付忠. 基于健康管理队列的心血管事件风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 56-60.
[8] 柳晓涓,蒋正,康凤玲,周苗,林伟强,薛付忠. 中性粒细胞计数与非酒精性脂肪肝关联性的前瞻性队列研究[J]. 山东大学学报(医学版), 2017, 55(6): 119-123.
[9] 于媛媛,王春霞,苏萍,孙苑潆,薛付忠,刘言训. 健康管理队列白内障发病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 104-107.
[10] 李敏,王春霞,夏冰,朱茜,孙苑潆,王淑康,薛付忠,贾红英. 健康管理人群脑卒中风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 93-97.
[11] 于珍珍,陈慧,杨晓云,吕明. 高尿酸血症、幽门螺杆菌感染与代谢综合征的相关性[J]. 山东大学学报(医学版), 2017, 55(5): 76-80.
[12] 柳晓涓,丁荔洁,康凤玲,周苗,薛付忠. 健康管理人群支气管哮喘风险预测模型[J]. 山东大学学报(医学版), 2017, 55(12): 56-61.
[13] 顾建华,马晓天,李吉庆,薛付忠,王家林. 健康管理队列慢性阻塞性肺疾病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(12): 62-65.
[14] 康凤玲,丁荔洁,柳晓涓,周苗,薛付忠. 多中心健康管理人群心脑血管疾病负担分析[J]. 山东大学学报(医学版), 2017, 55(12): 51-55.
[15] 杨洋,张光,张成琪,宋心红,薛付忠,王萍,王丽,刘言训. 基于体检队列的2型糖尿病风险预测模型[J]. 山东大学学报(医学版), 2016, 54(9): 69-72.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 高立芬,孙汶生,马春红,张利宁,梁晓红,王晓燕,郭春,陈有海 . pcDNA3-HBV瞬时转染对树突状细胞的影响[J]. 山东大学学报(医学版), 2007, 45(4): 325 -328 .
[2] 肖水清,杜毅,韩晶 . 正畸治疗过程中龈沟液内细菌变化的研究[J]. 山东大学学报(医学版), 2006, 44(5): 508 -510 .
[3] 毕爱玲,高建新,刘克敬,周玉琴. 三磷酸腺苷诱导体外培养的胚胎大鼠皮层神经细胞凋亡[J]. 山东大学学报(医学版), 2006, 44(12): 1194 -1196 .
[4] 刘义庆,王来城,焦玉莲,张捷,马春燕,崔彬,高新谱,刘正敏,张雪,赵跃然,. 人IL-26的基因克隆及其真核表达载体的构建[J]. 山东大学学报(医学版), 2006, 44(6): 541 -544 .
[5] 颜军昊,陈子江,李媛,胡京美,高姗姗. 体外受精周期中来源于单原核受精卵胚胎性染色体分析[J]. 山东大学学报(医学版), 2006, 44(6): 545 -548 .
[6] 孙建英,冯延秋,迟兆富,吴伟 . 海人酸致痫大鼠海马CA3区神经元线粒体损伤及妥泰的保护作用[J]. 山东大学学报(医学版), 2006, 44(6): 556 -559 .
[7] 费 玲,隋树建,任满意,许复郁,刘伟华,杜贻萌 . 实验性兔动脉粥样硬化病变中TRAIL、DR5的表达及意义[J]. 山东大学学报(医学版), 2007, 45(2): 135 -138 .
[8] 喻芳,周庚寅,张翠娟,高鹏,马超,李红. 原发性肝癌中HIF-1α、P-gp的表达及相关性的研究[J]. 山东大学学报(医学版), 2007, 45(3): 246 -249 .
[9] 赵红梅,赵蔚明,于修平,赵蕾,王红,郑燕,吕慧,李靖,刘娟,于晗. 沙眼衣原体感染对树突状细胞功能的影响[J]. 山东大学学报(医学版), 2007, 45(10): 973 -976 .
[10] 单宁宁,邹雄,张义,杨晓静,庄学伟,王洪春,侯明 . 小鼠LAK细胞MHC表达水平对其体外杀伤肿瘤活性的影响[J]. 山东大学学报(医学版), 2007, 45(11): 1096 -1100 .